2.5 Risk of bias assessment The risk of bias was assessed by two reviewers (LY, YY) respectively using the Cochrane Collaboration risk of bias tool for RCTs
The first reported case of drug-induced liver injury caused by semaglutide
Many patients feel different internally before they see external changes, and that's a normal and positive sign your body is responding to treatment
A pilot study even identified specific microbial patterns that distinguished responders from non-responders in a group of 52 patients
The RiboCeine patent our scientists earned ensures, by law, that only Max can offer and manufacture our industry-leading, superior technology
However, it does have prescription approval in some countries for anxiety disorders, which is promising for future approval